Sreshta Regulatory Writing Email Formats
Research Services • • 1-10 Employees
Key Contact at Sreshta Regulatory Writing
Linda Sreshta
President
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 5417 |
| Keywords | Regulatory Writing, Investigator Brochures, Orphan Drug Designation, Clinical Study Reports, Briefing Documents / Meeting Packages, Clinical Submission Documents, Fast Track / Breakthrough Therapy Designations, Ind And Cta Components, Module 2 Summaries, Nda/Bla/Maa Submission Documents, Pediatric Study Plans / Pips |
| Founded | 2025 |
| Employees | 1-10 |
About Sreshta Regulatory Writing
With over 30 years of experience in the pharmaceutical and biotechnology industries, I specialize in regulatory and scientific medical writing that supports the full spectrum of drug development—from early-stage research to global regulatory submissions. I bring deep expertise in authoring and managing critical documentation for INDs, CTAs, and global marketing applications across a wide range of therapeutic areas. I offer expert-level writing services including Briefing Packages, General Investigational Plans, Clinical Overviews, Integrated Summaries of Safety and Efficacy, Pediatric Plans, Orphan Drug and Fast Track Designations, Protocols, Clinical Study Reports, and more. Sreshta Regulatory Writing: Trusted Expertise. Submission-ready results.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Sreshta Regulatory Writing has never raised funding before.
Egypt
United Kingdom
South Africa
Germany
FranceFrequently asked questions
4.8
40,000 users
